These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2499960)

  • 21. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.
    Austen DE; Smith JK
    Thromb Haemost; 1982 Aug; 48(1):46-8. PubMed ID: 6813994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyvinylpyrrolidone (PVP): a new precipitating agent for human and bovine factor VIII and fibrinogen.
    Casillas G; Simonetti C
    Br J Haematol; 1982 Apr; 50(4):665-72. PubMed ID: 6802165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A new human factor VIII concentrate. Preparation and clinical use].
    Simonetti C; Casillas G; Farías C; De los Santos JC
    Medicina (B Aires); 1981; 41 Suppl():249-52. PubMed ID: 6808288
    [No Abstract]   [Full Text] [Related]  

  • 25. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
    Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
    Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor VIII collection by pheresis.
    McLeod BC; Sassetti RJ; Cole ER; Pierce MI
    Lancet; 1980 Sep; 2(8196):671-3. PubMed ID: 6106786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An improved thaw-siphon method for the cryoprecipitate preparation.
    Kang EP
    Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of plasma with high levels of ionised calcium in the production of model scale coagulation factor concentrates.
    Farrugia A; Douglas S; James J; Whyte G; Herrington R
    Thromb Haemost; 1990 Nov; 64(3):374-8. PubMed ID: 2128967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of factor VIII concentrates by cryoprecipitate sedimentation.
    Boudart DJ; Naud MF
    Transfusion; 1979; 19(5):594-6. PubMed ID: 505533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A factor VIII concentrate of intermediate purity and higher potency.
    Smith JK; Evans DR; Stone V; Snape TJ
    Transfusion; 1979; 19(3):299-306. PubMed ID: 36691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionation of individual, biologically active factor VIII multimers.
    Perret BA; Furlan M; Kneubuehl F; Beck EA
    Biochim Biophys Acta; 1981 Jun; 669(1):98-104. PubMed ID: 6794637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Isolation and some properties of factor VIII (antihemophilic factor)].
    Bykowska K; Lopaciuk S; Michalski R
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):283-92. PubMed ID: 998139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of cryoprecipitated factor VIII concentrates.
    Slichter SJ; Counts RB; Henderson R; Harker LA
    Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor VIII concentrate prepared from blood donors stimulated by intranasal administration of a vasopressin analogue.
    Mikaelsson M; Nilsson IM; Vilhardt H; Wiechel B
    Transfusion; 1982; 22(3):229-33. PubMed ID: 6806950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategy for purification of coagulation factor concentrates.
    Clark DB; Drohan WN; Miekka SI; Katz AJ
    Ann Clin Lab Sci; 1989; 19(3):196-207. PubMed ID: 2658728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term kidney preservation with a new plasma perfusate.
    Toledo-Pereyra LH; Condie RM; Malmberg R; Simmons RL; Najarian JS
    Proc Clin Dial Transplant Forum; 1973; 3():88-91. PubMed ID: 4619690
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the procurement of coagulation factor VIII: selective precipitation of factor VIII with hydrophilic polymers.
    Farrugia A; Griffin B; Pepper D; Prowse C
    Thromb Haemost; 1984 Jul; 51(3):338-42. PubMed ID: 6437004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Substitution of antihemophilic globulin (factor VIII) with special reference to Pool's cold fractionation].
    Matthes M; Engbring H; Winckelmann G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):434-40. PubMed ID: 4107580
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of 'single donor' factor VIII from plasma exchange donation.
    McLeod BC; Scott JP
    JAMA; 1984 Nov; 252(19):2726-9. PubMed ID: 6436520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings: Improved factor VIII yield in cryoprecipitate using a quick thaw technique.
    Davidson JF; McAdam JH; Mackenzie MJ; Kavanagh ML
    Thromb Diath Haemorrh; 1975 Nov; 34(2):590. PubMed ID: 1198502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.